Variant report
Variant | esv3515084 |
---|---|
Chromosome Location | chr7:16237107-16238413 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543165325 | chr7:16237126-16237127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10232023 | chr7:16237180-16237181 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs113463085 | chr7:16237197-16237198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561226183 | chr7:16237208-16237209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs113363531 | chr7:16237210-16237211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574052800 | chr7:16237261-16237262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138029897 | chr7:16237347-16237348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563153278 | chr7:16237351-16237352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs578215424 | chr7:16237352-16237353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545579512 | chr7:16237398-16237399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142561039 | chr7:16237400-16237401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528157559 | chr7:16237426-16237427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs13245605 | chr7:16237431-16237432 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs561469756 | chr7:16237463-16237464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528813516 | chr7:16237468-16237469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs71540739 | chr7:16237472-16237473 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs149358140 | chr7:16237487-16237488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539400817 | chr7:16237492-16237493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs375410542 | chr7:16237514-16237515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566586129 | chr7:16237539-16237540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533997047 | chr7:16237540-16237541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs555848920 | chr7:16237550-16237551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs574188948 | chr7:16237552-16237553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538230308 | chr7:16237584-16237585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556329580 | chr7:16237631-16237632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs578179948 | chr7:16237640-16237641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs13245843 | chr7:16237689-16237690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545410238 | chr7:16237745-16237746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560855023 | chr7:16237875-16237876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527241964 | chr7:16237886-16237887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs13311519 | chr7:16237988-16237989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs144658771 | chr7:16238029-16238030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375007166 | chr7:16238046-16238047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528996285 | chr7:16238047-16238048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7812252 | chr7:16238138-16238139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562375335 | chr7:16238274-16238275 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554336821 | chr7:16238343-16238344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11415283 | chr7:16238350-16238351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6946244 | chr7:16238365-16238366 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs566773213 | chr7:16238368-16238369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs527440436 | chr7:16238390-16238391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs375160810 | chr7:16238412-16238413 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567756833 | chr7:16238413-16238414 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Rubinstein-Taybi syndrome | 22470819 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Bladder cancer | 21909424 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 19805367 | CNVD |
Autism | 20808228 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:16234000-16238400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr7:16234400-16238400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr7:16234400-16238600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr7:16234800-16244000 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
5 | chr7:16237000-16238200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
6 | chr7:16238200-16239000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr7:16238400-16239000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr7:16238400-16239800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |